Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Sanofi Ord Shs SNYNF

Healthcare

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more

Add To Watchlist

Recent & Breaking News (OTCPK:SNYNF)

Regeneron and Sanofi Announce Positive Topline Results from First Phase 3 Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia

PR Newswire January 9, 2015

SHAREHOLDER ALERT: Investigation on Behalf of Investors of Sanofi Announced by Law Offices of Howard G. Smith

Business Wire January 6, 2015

Nova Scotia funds treatment with AUBAGIO(TM) for Relapsing Remitting Multiple Sclerosis

Canada NewsWire January 5, 2015

SANOFI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Sanofi

Business Wire January 2, 2015

Shareholder Alert: Pomerantz Law Firm Announces the Filing of a Class Action against Sanofi and Certain Officers - SNY

PR Newswire January 2, 2015

INVESTOR ALERT: Investigation on Behalf of Investors of Sanofi Announced by Glancy Binkow & Goldberg LLP

Business Wire December 30, 2014

SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sanofi SA and Its Board of Directors and a Lead Plaintiff Deadline of February 2, 2015 -- SNY

GlobeNewswire December 29, 2014

Lieff Cabraser Announces Class Action Litigation Against Sanofi - SNY

Business Wire December 22, 2014

EQUITY ALERT: Rosen Law Firm Reminds Sanofi Investors of Important Class Action Deadline - SNY

GlobeNewswire December 21, 2014

SANOFI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sanofi -- SNY

GlobeNewswire December 20, 2014

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Sanofi of Class Action Lawsuit and Upcoming Deadline -- SNY

GlobeNewswire December 19, 2014

The Yukon to fund treatment with AUBAGIO(TM) for Relapsing Remitting Multiple Sclerosis

Canada NewsWire December 18, 2014

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Sanofi To Contact Brower Piven Before The February 2, 2015 Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire December 16, 2014

Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol

PR Newswire December 15, 2014

Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults

PR Newswire December 12, 2014

SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sanofi SA and Its Board of Directors and a Lead Plaintiff Deadline of February 2, 2015 -- SNY

GlobeNewswire December 11, 2014

British Columbia funds treatment with AUBAGIO(TM) for Relapsing Remitting Multiple Sclerosis

Canada NewsWire December 11, 2014

Robbins Arroyo LLP: Sanofi (SNY) Misled Shareholders According to a Recently Filed Class Action

GlobeNewswire December 10, 2014

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Sanofi to Contact Brower Piven Before the February 2, 2015 Lead Plaintiff Deadline in Class Action Lawsuit -- SNY

GlobeNewswire December 9, 2014

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Sanofi

Business Wire December 8, 2014